Search

Your search keyword '"Rickert, Keith"' showing total 209 results

Search Constraints

Start Over You searched for: Author "Rickert, Keith" Remove constraint Author: "Rickert, Keith"
209 results on '"Rickert, Keith"'

Search Results

1. A Diene‐Containing Noncanonical Amino Acid Enables Dual Functionality in Proteins: Rapid Diels–Alder Reaction with Maleimide or Proximity‐Based Dimerization

3. Integration of Affinity Selection–Mass Spectrometry and Functional Cell-Based Assays to Rapidly Triage Druggable Target Space within the NF-κB Pathway

4. Structural characterization of nonactive site, TrkA-selective kinase inhibitors

10. Developability profiling of a panel of Fc engineered SARS-CoV-2 neutralizing antibodies

18. Temperature-dependent isotope effects in soybean lipoxygenase-1: correlating hydrogen tunneling with protein dynamics

19. A Diene-Containing Noncanonical Amino Acid Enables Dual Functionality in Proteins: Rapid Diels-Alder Reaction with Maleimide or Proximity-Based Dimerization

22. Antibody Fragment F(ab′)2 Targeting Caveolae-Associated Protein PV1 for Selective Kidney Targeting and Retention

23. Experimentally guided computational antibody affinity maturation with de novo docking, modelling and rational design

24. Improved Inhibition of Tumor Growth by Diabody-Drug Conjugates via Half-Life Extension

25. Human Relaxin-2 Fusion for the Treatment of Heart Failure

26. Tricyclic 1,5-naphthyridinone oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents-SAR of left-hand-side moiety (Part-2)

27. Characterization of non-active site TrkA selective kinase inhibitors and implications on obtaining kinase selectivity

28. Structural characterization of nonactive site, TrkA-selective kinase inhibitors

29. The TGF-β inhibitory activity of antibody 37E1B5 depends on its H-CDR2 glycan

31. Ultrasmall targeted nanoparticles with engineered antibody fragments for imaging detection of HER2-overexpressing breast cancer.

32. Antibody Fragment F(ab′)2Targeting Caveolae-Associated Protein PV1 for Selective Kidney Targeting and Retention

36. Target-Agnostic Identification of Functional Monoclonal Antibodies AgainstKlebsiella pneumoniaeMultimeric MrkA Fimbrial Subunit

37. Maximizing Diversity from a Kinase Screen: Identification of Novel and Selective pan-Trk Inhibitors for Chronic Pain

38. Development of thioquinazolinones, allosteric Chk1 kinase inhibitors

39. Oxabicyclooctane-Linked Novel Bacterial Topoisomerase Inhibitors as Broad Spectrum Antibacterial Agents

40. Structural characterization of nonactive site, TrkA-selective kinase inhibitors.

42. Target-Agnostic Identification of Functional Monoclonal Antibodies Against Klebsiella pneumoniae Multimeric MrkA Fimbrial Subunit.

43. Discovery of 1-[3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): A Specific c-Met/Ron Dual Kinase Inhibitor with Preferential Affinity for the Activated State of c-Met

44. Discovery of a 5H-Benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) Inhibitor of c-Met Kinase for the Treatment of Cancer

45. Expression, purification and crystallization of human prolylcarboxypeptidase

47. Structural definition and substrate specificity of the S28 protease family: the crystal structure of human prolylcarboxypeptidase

48. Synthesis and evaluation of substituted benzoisoquinolinones as potent inhibitors of Chk1 kinase

49. Optimization of a pyrazoloquinolinone class of Chk1 kinase inhibitors

50. Kinesin spindle protein (KSP) inhibitors. Part 7: Design and synthesis of 3,3-disubstituted dihydropyrazolobenzoxazines as potent inhibitors of the mitotic kinesin KSP

Catalog

Books, media, physical & digital resources